Combination therapy based on a bone-targeted Notch inhibitor and anti-Sclerostin antibody simultaneously decreases tumor burden and rebuilds damaged bone in mice with established myeloma disease

JOURNAL OF BONE AND MINERAL RESEARCH(2023)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要